Fpc Investment Advisory, Inc. Fate Therapeutics Inc Transaction History
Fpc Investment Advisory, Inc.
- $137 Billion
- Q4 2024
A detailed history of Fpc Investment Advisory, Inc. transactions in Fate Therapeutics Inc stock. As of the latest transaction made, Fpc Investment Advisory, Inc. holds 26,456 shares of FATE stock, worth $23,281. This represents 0.03% of its overall portfolio holdings.
Number of Shares
26,456Holding current value
$23,281% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding FATE
# of Institutions
167Shares Held
101MCall Options Held
41.3KPut Options Held
15.9K-
Redmile Group, LLC San Francisco, CA12.9MShares$11.3 Million1.66% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.3MShares$9.09 Million0.0% of portfolio
-
Black Rock Inc. New York, NY10.1MShares$8.9 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V84.84MShares$4.26 Million0.16% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il4.38MShares$3.86 Million0.0% of portfolio
About FATE THERAPEUTICS INC
- Ticker FATE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,000,304
- Market Cap $85.4M
- Description
- Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...